PT-141 (Bremelanotide)
100% Online — No Office Visit Required
PT-141 (bremelanotide) is a melanocortin receptor agonist that activates sexual arousal pathways in the central nervous system — offering a different mechanism from PDE5 inhibitors for sexual dysfunction.
What Is PT-141?
PT-141 (bremelanotide) is an analogue of alpha-MSH that binds melanocortin receptors (MC3R, MC4R) in the central nervous system, activating dopaminergic pathways involved in sexual arousal and desire.
What It May Help With
PT-141 is used for:
- Hypoactive sexual desire disorder (HSDD)
- ED that doesn't respond to PDE5 inhibitors
- Low libido in both men and women
How OakMD Works
OakMD is a telemedicine platform connecting eligible adults with licensed providers. If you're interested in PT-141, the process begins with a brief online intake form. A licensed provider will review your health history, symptoms, and goals — and determine if treatment is appropriate for you.
If you are a candidate, your provider will create a personalized treatment plan and guide you through next steps. There are no in-person visits required.
Common Questions
Is PT-141 the same as Vyleesi?
Yes. Vyleesi is the FDA-approved brand of bremelanotide, approved for HSDD in premenopausal women. PT-141 is the research name used in clinical and off-label contexts.
Ready to Get Started?
Complete a brief online intake. A licensed provider will review your information and determine if treatment is appropriate for you.
Medical Disclaimer: The information on this page is provided for educational purposes only and does not constitute medical advice. OakMD is a telemedicine platform. All treatments are prescription-based, subject to provider review, and may not be appropriate for all individuals. A licensed provider will evaluate your medical history and determine eligibility. Consult a qualified healthcare professional before starting any new treatment.